New Cholesterol Guidelines: Screening, Risk, and Targets

Big changes in cholesterol guidelines will spark conversations about managing patients withOUT atherosclerotic cardiovascular disease (ASCVD).

Be ready to discuss earlier screening and treatment...LDL-C targets...and the role of CV risk markers (lipoprotein(a), etc).

Screening. Recommend a lipid profile (fasting or nonfasting) for patients between ages 9 and 11 years...and again at 19 years.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote